Science Daily16m
New options for controlling type 2 diabetes
Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.
New options for controlling type 2 diabetes in patients who stop medication
Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year ...
Organon buys rights to Biogen’s biosimilar targeting Roche’s Actemra
Organon (OGN) stock in focus as the Merck (MRK) spinoff buys rights to Biogen's (BIIB) biosimilar Tofidence, targeting ...
EMBO Press8h
Dimerization of GAS2 mediates crosslinking of microtubules and F-actin
GAS2 is a cytoskeletal regulator that interacts with both F-actin and microtubules. Here, cryo-EM structures of GAS2 domains ...
Dual protein tagging process could lead to new treatments for immune system diseases
A study by Oregon Health & Science University researchers has uncovered a new way proteins can be changed inside cells. This ...